This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2007 Jan;143(1):125-6.

doi: 10.1001/archderm.143.1.125.

Bosentan as a rescue therapy in scleroderma refractory digital ulcers

Melanie Chamaillard, Isabelle Heliot-Hosten, Joël Constans, Alain Taïeb

PMID: 17224564
DOI: 10.1001/archderm.143.1.125

Case Reports

Bosentan as a rescue therapy in scleroderma refractory digital ulcers

Melanie Chamaillard et al. Arch Dermatol. 2007 Jan.

. 2007 Jan;143(1):125-6.

doi: 10.1001/archderm.143.1.125.

Authors

Melanie Chamaillard, Isabelle Heliot-Hosten, Joël Constans, Alain Taïeb

PMID: 17224564
DOI: 10.1001/archderm.143.1.125

No abstract available

PubMed Disclaimer

Similar articles

Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.
Tsifetaki N, Botzoris V, Alamanos Y, Argyriou E, Zioga A, Drosos AA. Tsifetaki N, et al. J Rheumatol. 2009 Jul;36(7):1550-2. doi: 10.3899/jrheum.080992. J Rheumatol. 2009. PMID: 19567637 No abstract available.
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.
Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, Rich E, Carpentier P, Molitor J, Seibold JR, Hsu V, Guillevin L, Chatterjee S, Peter HH, Coppock J, Herrick A, Merkel PA, Simms R, Denton CP, Furst D, Nguyen N, Gaitonde M, Black C. Korn JH, et al. Arthritis Rheum. 2004 Dec;50(12):3985-93. doi: 10.1002/art.20676. Arthritis Rheum. 2004. PMID: 15593188 Clinical Trial.
Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy.
Tillon J, Hervé F, Chevallier D, Muir JF, Levesque H, Marie I. Tillon J, et al. Br J Dermatol. 2006 May;154(5):1000-2. doi: 10.1111/j.1365-2133.2006.07194.x. Br J Dermatol. 2006. PMID: 16634913 No abstract available.
Raynaud, digital ulcers and calcinosis in scleroderma.
Nitsche A. Nitsche A. Reumatol Clin. 2012 Sep-Oct;8(5):270-7. doi: 10.1016/j.reuma.2012.02.006. Epub 2012 Jul 25. Reumatol Clin. 2012. PMID: 22835924 Review.
[Management of digital ulcers in patients with systemic sclerosis].
Riemekasten G, Hoffmann U, Sunderkötter C, Weiss N, Kuhn A; angiologisch-dermatologisch-rheumatologische DU-Expertenboard. Riemekasten G, et al. Dtsch Med Wochenschr. 2012 Jan;137(1-2):34-40. doi: 10.1055/s-0031-1298798. Epub 2011 Dec 16. Dtsch Med Wochenschr. 2012. PMID: 22180282 Review. German. No abstract available.

See all similar articles

Cited by

[Treatment of a leg ulcer with bosentan in a female patient with progressive systemic scleroderma].
Rösener I, Rübben A. Rösener I, et al. Hautarzt. 2007 May;58(5):392-3. doi: 10.1007/s00105-007-1336-7. Hautarzt. 2007. PMID: 17450342 German. No abstract available.
Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis.
Arefiev K, Fiorentino DF, Chung L. Arefiev K, et al. Int J Rheumatol. 2011;2011:201787. doi: 10.1155/2011/201787. Epub 2011 Oct 27. Int J Rheumatol. 2011. PMID: 22121371 Free PMC article.
Effects of bosentan on the skin lesions: an observational study from a single center in Japan.
Funauchi M, Kishimoto K, Shimazu H, Nagare Y, Hino S, Yano T, Kinoshita K. Funauchi M, et al. Rheumatol Int. 2009 May;29(7):769-75. doi: 10.1007/s00296-008-0789-z. Epub 2008 Nov 27. Rheumatol Int. 2009. PMID: 19037604 Clinical Trial.
Swift and Complete Healing of Digital Ulcers after Macitentan Treatment.
Giner Serret E. Giner Serret E. Case Rep Rheumatol. 2016;2016:1718309. doi: 10.1155/2016/1718309. Epub 2016 Nov 22. Case Rep Rheumatol. 2016. PMID: 27994906 Free PMC article.
Digital ulcers in scleroderma patients: A retrospective observational study.
De Cata A, Inglese M, Molinaro F, De Cosmo S, Rubino R, Bernal M, Mazzoccoli G. De Cata A, et al. Int J Immunopathol Pharmacol. 2016 Jun;29(2):180-7. doi: 10.1177/0394632015606846. Epub 2015 Dec 18. Int J Immunopathol Pharmacol. 2016. PMID: 26684622 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information